最高法院扩大快速消费品藐视法庭案件范围以解决欺骗性广告行为

最高法院将对误导性广告的审查范围扩大到 Patanjali Ayurved 以外的所有快速消费品 (FMCG) 公司。法院认识到对公共利益的更广泛影响，关注范围扩大到所有发布欺骗性主张的实体。在帕坦贾利藐视法庭案的听证会上，法院质疑该公司公开道歉的诚意，并指示中央部委提供政府针对误导性广告所采取行动的详细信息。

Supreme Court Expands Scope of Patanjali Contempt Case to Tackle Misleading FMCG Advertisements

最高法院扩大帕坦贾利藐视法庭案的范围以解决误导性快速消费品广告

New Delhi, India: In a landmark ruling, the Supreme Court of India today sent shockwaves through the country's Fast-Moving Consumer Goods (FMCG) industry. The Court clarified that its contempt proceedings against Patanjali Ayurved, triggered by the company's deceptive advertising practices, are not solely focused on Patanjali as an isolated entity. Rather, the Court's mandate extends to the entire realm of FMCG companies that persistently publish misleading advertisements, a practice that has become rampant in recent years.

印度新德里：印度最高法院今天做出了一项具有里程碑意义的裁决，震惊了该国的快速消费品 (FMCG) 行业。法院澄清，由于 Patanjali Ayurved 公司的欺骗性广告行为而引发的藐视法庭诉讼不仅仅针对 Patanjali 作为一个孤立的实体。相反，法院的授权范围涵盖了持续发布误导性广告的整个快速消费品公司，这种做法近年来变得猖獗。

The Court, presided over by a three-judge bench, grilled Baba Ramdev and Acharya Balkrishna, the enigmatic duo behind Patanjali Ayurved, questioning the sincerity of their recent public apology published in newspapers. The bench pointedly asked if the apology was of comparable size and cost to the sprawling front-page advertisements the company regularly employs to promote its herbal remedies.

法庭由三名法官主持，对帕坦贾利·阿育维背后的神秘二人组巴巴·拉姆德夫和阿查里亚·巴尔克里希纳进行了质问，质疑他们最近在报纸上发表的公开道歉的诚意。法官们尖锐地询问，此次道歉的规模和成本是否与该公司经常使用的大量头版广告来宣传其草药疗法相当。

The Court's scrutiny extended beyond Patanjali. It issued a stern warning to the petitioner, the Indian Medical Association (IMA), expressing concern over allegations of unethical practices within the allopathic medical community. The judges emphasized the need for fair and unbiased practices across the entire healthcare sector.

法院的审查范围超出了帕坦贾利的范围。它向请愿者印度医学协会（IMA）发出严厉警告，对对抗疗法医学界的不道德行为指控表示担忧。法官们强调整个医疗保健行业需要公平和公正的做法。

Expanding the scope of the case, the Supreme Court instructed central government ministries to submit detailed affidavits outlining their actions over the past three years to curb misleading advertisements. This unprecedented move signals the Court's determination to address the pervasive issue of false and deceptive marketing claims that harm consumers and erode public trust.

为了扩大案件范围，最高法院指示中央政府各部委提交详细的宣誓书，概述他们在过去三年中遏制误导性广告的行动。这一史无前例的举措标志着法院决心解决损害消费者和削弱公众信任的虚假和欺骗性营销主张这一普遍存在的问题。

The IMA had initiated contempt proceedings against Patanjali Ayurved after the company published a series of advertisements that allegedly made extravagant claims of curing various diseases and subtly disparaged modern medicine. The IMA, an umbrella organization representing over 2.5 lakh doctors in India, has been a vocal critic of Patanjali's advertising practices, accusing the company of misleading the public and undermining the reputation of allopathic medicine.

在Patanjali Ayurved公司发布了一系列广告，据称这些广告夸大地声称可以治愈多种疾病并巧妙地贬低现代医学后，IMA对Patanjali Ayurved提起了藐视法庭诉讼。 IMA 是代表印度超过 25 万名医生的伞式组织，一直直言不讳地批评 Patanjali 的广告做法，指责该公司误导公众并损害了对抗疗法的声誉。

The Supreme Court's momentous ruling has sent a clear message to FMCG companies: the era of unbridled false advertising is over. The Court's resolve to protect consumers from misleading claims and ensure fair competition within the healthcare sector has set a groundbreaking precedent that is expected to shape the industry landscape in the years to come.

最高法院的重大判决向快消品企业发出了明确的信息：肆无忌惮的虚假广告时代已经结束。法院决心保护消费者免受误导性主张并确保医疗保健行业内的公平竞争，这树立了开创性的先例，预计将在未来几年塑造行业格局。